Financials & SEC Filings - Stoke Therapeutics

Filing date	Description	Form	View
April 27, 2023	Additional proxy soliciting materials - definitive	DEFA14A	0001193125-23-122102.pdf 0001193125-23-122102.rtf View HTML
April 27, 2023	An annual report to security holders	ARS	0001193125-23-122150.pdf 0001193125-23-122150.rtf View HTML
April 17, 2023	A preliminary proxy statement providing notification matters to be brought to a vote	PRE 14A	0001193125-23-103615.pdf 0001193125-23-103615.rtf 0001193125-23-103615.xls View HTML
April 13, 2023	Securities offered to employees pursuant to employee benefit plans	S-8	0001193125-23-100506.pdf 0001193125-23-100506.rtf 0001193125-23-100506.xls View HTML
March 22, 2023	Securities offered to employees pursuant to employee benefit plans	S-8	0001193125-23-076715.pdf 0001193125-23-076715.rtf 0001193125-23-076715.xls View HTML
March 17, 2023	Initial filing by director officer or owner of more than ten percent.	3	0001209191-23-019564.pdf 0001209191-23-019564.rtf 0001209191-23-019564.xls View HTML
March 17, 2023	Statement of changes in beneficial ownership of securities	4	0001209191-23-019653.pdf 0001209191-23-019653.rtf 0001209191-23-019653.xls View HTML
March 17, 2023	Statement of changes in beneficial ownership of securities	4	0001209191-23-019662.pdf 0001209191-23-019662.rtf 0001209191-23-019662.xls View HTML
March 17, 2023	Statement of changes in beneficial ownership of securities	4	0001209191-23-019656.pdf 0001209191-23-019656.rtf 0001209191-23-019656.xls View HTML
March 17, 2023	Statement of changes in beneficial ownership of securities	4	0001209191-23-019669.pdf 0001209191-23-019669.rtf 0001209191-23-019669.xls View HTML

Data provided by Kaleidoscope.